Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 17/20 | 0.48 |
| ▸ | CTSD | P07339 | 4/20 | 0.48 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | CTSB | P07858 | 1/20 | 0.39 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3354961 | 1.00 | BACE1 (0.48) | BACE1CTSDBCHECTSBBACE2 | |
| SCHEMBL3178597 | 1.00 | BACE1 (0.48) | BACE1CTSDBCHECTSBBACE2 | |
| SCHEMBL3351909 | 0.90 | BACE1 (0.52) | BACE1CTSDCTSBBACE2 | |
| SCHEMBL4041091 | 0.87 | BCHE (0.51) | BACE1BCHECYP1A2CYP2D6CYP2C19 | |
| SCHEMBL3357034 | 0.86 | BCHE (0.49) | BACE1CTSDBCHEBACE2 | |
| SCHEMBL2874563 | 0.85 | BACE1 (0.53) | BACE1CTSDCTSB | |
| SCHEMBL3352827 | 0.85 | BACE1 (0.57) | BACE1CTSDCTSBBACE2 | |
| SCHEMBL3349064 | 0.85 | BACE1 (0.53) | BACE1CTSDCTSB | |
| SCHEMBL3348880 | 0.85 | LMNA (0.50) | BACE1CTSDCTSBCYP1A2CYP2D6 | |
| SCHEMBL3356792 | 0.85 | BACE1 (0.59) | BACE1CTSDCTSBBACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1565443-A4 | ACETYL 2-HYDROXY-1,3 DIAMINOALKANES | ELAN PHARM INC (US) | 2007-07-18 | — | — | EP | disclosed |
| EP-1565443-A2 | ACETYL 2-HYDROXY-1,3 DIAMINOALKANES | Elan Pharmaceuticals, Inc. (US) | 2005-08-24 | — | — | EP | disclosed |
| WO-2004024081-A2 | ACETYL 2-HYDROXY-1,3 DIAMINOALKANES | ELAN PHARMACEUTICALS, INC. (US) | 2004-03-25 | — | — | WO | disclosed |